Tadalafil labels and packages

Tadalafil
ADCIRCA (tadalafil) tablet ^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here

Labels and Packages

Manufactured by: Eli Lilly and Company, Indianapolis, IN 46285, USA

Marketed by: Lung LLC, a wholly-owned subsidiary of United Therapeutics Corporation

PV 6485 AMP

PACKAGE LABEL – ADCIRCA 20 mg 60 count bottle

60 tablets

NDC 66302-467-60

Rx only

TA 4467

adcirca®

tadalafil tablets

20 mg

Lung LLCTM

Lilly

Same active ingredient as Cialis